BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28

• Drug Development

  Takeda Pharmaceutical Co. Ltd. Release: American Society of Clinical Oncology Presentation Highlights Results of Single Agent oral MLN9708 in Heavily Pretreated Patients with Relapsed and/or Refractory Multiple Myeloma

  June 3, 2013

   · 

  1 min read
• Biotech Beach

  Grant Established by Bioness Inc. and Stroke Survivor Will Provide Bioness L300® Foot Drop Systems to Stroke Patients in Need

  June 3, 2013

   · 

  1 min read
• BioCapital

  ResMed Inc. Launches SleepSeeker Online Tool to Increase Patient Engagement in Therapy for Sleep-Disordered Breathing

  June 3, 2013

   · 

  2 min read
• Drug Development

  Progenics Pharmaceuticals, Inc.’ Data From a Phase 1 Study of PSMA ADC Presented at American Society of Clinical Oncology 2013

  June 3, 2013

   · 

  1 min read
• Pharm Country

  Becton, Dickinson and Company Release: New Prefillable Syringe System Offers Advanced Glass Technology for Biopharmaceutical Injectable Drug Delivery

  June 3, 2013

   · 

  2 min read
• Deals

  BioMed Realty and Wexford Science & Technology, LLC Complete Merger

  June 3, 2013

   · 

  6 min read
• Drug Development

  Celator Pharmaceuticals, Inc. Announces New Data on Factors Associated With Outcomes in AML Patients Treated With CPX-351

  June 3, 2013

   · 

  1 min read
• Deals

  Kettering Medical Center Acquires Elekta’s Versa HD Radiotherapy System

  June 3, 2013

   · 

  3 min read
• Biotech Bay

  DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at American Society of Clinical Oncology

  June 3, 2013

   · 

  9 min read
• BioMidwest

  Seattle Genetics, Inc. Highlights ADCETRIS® (Brentuximab Vedotin) Frontline HL and MTCL Clinical Development Programs and Antibody-Drug Conjugate (ADC) Collaborator Data at American Society of Clinical Oncology Annual Meeting

  June 3, 2013

   · 

  1 min read